File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A prospective study of the impact of glycaemic status on clinical outcomes and anti-SARS-CoV-2 antibody responses among patients with predominantly non-severe COVID-19

TitleA prospective study of the impact of glycaemic status on clinical outcomes and anti-SARS-CoV-2 antibody responses among patients with predominantly non-severe COVID-19
Authors
Lui, TWDLI, YKLee, CHPCHOW, WSLEE, ACHTAM, ARPang, KPPHo, TYCheung, YYFong, HYTO, KKWTan, KCBWOO, YCHung, FNILam, KSL
Issue Date2022
Citation
Diabetes Research and Clinical Practice, 2022, v. 185, p. 109232 How to Cite?
DOI: http://dx.doi.org/10.1016/j.diabres.2022.109232
AbstractAims: We carried out this prospective study of predominantly non-severe COVID-19 patients, to evaluate the influence of glycaemic status on clinical outcomes and neutralising antibody (Nab) responses, potentially relevant to the COVID-19 vaccination programme.
Persistent Identifierhttp://hdl.handle.net/10722/317394
ISI Accession Number ID
WOS:000820101600015

 

DC FieldValueLanguage
dc.contributor.authorLui, TWD-
dc.contributor.authorLI, YK-
dc.contributor.authorLee, CHP-
dc.contributor.authorCHOW, WS-
dc.contributor.authorLEE, ACH-
dc.contributor.authorTAM, AR-
dc.contributor.authorPang, KPP-
dc.contributor.authorHo, TY-
dc.contributor.authorCheung, YY-
dc.contributor.authorFong, HY-
dc.contributor.authorTO, KKW-
dc.contributor.authorTan, KCB-
dc.contributor.authorWOO, YC-
dc.contributor.authorHung, FNI-
dc.contributor.authorLam, KSL-
dc.date.accessioned2022-10-07T10:19:43Z-
dc.date.available2022-10-07T10:19:43Z-
dc.date.issued2022-
dc.identifier.citationDiabetes Research and Clinical Practice, 2022, v. 185, p. 109232-
dc.identifier.urihttp://hdl.handle.net/10722/317394-
dc.description.abstractAims: We carried out this prospective study of predominantly non-severe COVID-19 patients, to evaluate the influence of glycaemic status on clinical outcomes and neutralising antibody (Nab) responses, potentially relevant to the COVID-19 vaccination programme.-
dc.languageeng-
dc.relation.ispartofDiabetes Research and Clinical Practice-
dc.titleA prospective study of the impact of glycaemic status on clinical outcomes and anti-SARS-CoV-2 antibody responses among patients with predominantly non-severe COVID-19-
dc.typeArticle-
dc.identifier.emailLui, TWD: dtwlui@hku.hk-
dc.identifier.emailLee, CHP: pchlee@hku.hk-
dc.identifier.emailPang, KPP: pollpang@hku.hk-
dc.identifier.emailHo, TY: tipyinho@hku.hk-
dc.identifier.emailCheung, YY: cyy0219@hku.hk-
dc.identifier.emailFong, HY: kalofong@hku.hk-
dc.identifier.emailTan, KCB: kcbtan@hkucc.hku.hk-
dc.identifier.emailHung, FNI: ivanhung@hkucc.hku.hk-
dc.identifier.emailLam, KSL: ksllam@hku.hk-
dc.identifier.authorityLui, TWD=rp02803-
dc.identifier.authorityLee, CHP=rp02043-
dc.identifier.authorityCheung, YY=rp02243-
dc.identifier.authorityTan, KCB=rp00402-
dc.identifier.authorityHung, FNI=rp00508-
dc.identifier.authorityLam, KSL=rp00343-
dc.identifier.doi10.1016/j.diabres.2022.109232-
dc.identifier.hkuros337195-
dc.identifier.volume185-
dc.identifier.spage109232-
dc.identifier.epage109232-
dc.identifier.isiWOS:000820101600015-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats